REQUEST A DEMO
Total
USD $0.00
Search more companies

Clinomics Inc. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Clinomics Inc. Profile Updated: July 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

The Company is a Korea-based company engaged in the development of genome diagnostic tests and liquid biopsies. The Company s main businesses are multi-omics-based service business and liquid biopsy-based cancer diagnosis and screening business. The multi-omics-based service business provides products and services that predict physical characteristics and diseases based on genome diagnosis and tests, and provides early diagnosis services for major diseases such as cancer based on multi-omics. The liquid biopsy-based cancer diagnosis and screening business sells medical devices that diagnose patients by extracting blood cells and deoxyribonucleic acid (DNA), and diagnostic and monitoring kits for cancer mutations in patients. It is also develops products that diagnoses cancer early with blood. The Company was established on June 21, 2011. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on December 4, 2020.

Headquarters
Suite 301-3, Bldg. 110, Unist, 50, Unist-Gil, Eonyang-Eup, Ulju-Gun
Ulsan; Ulsan;

Contact Details: Purchase the Clinomics Inc. report to view the information.

Website: http://www.clinomics.com

Basic Information
Total Employees:
Purchase the Clinomics Inc. report to view the information.
Outstanding Shares:
Purchase the Clinomics Inc. report to view the information.
Registered Capital:
Purchase the Clinomics Inc. report to view the information.
Financial Auditors:
Purchase the Clinomics Inc. report to view the information.
Incorporation Date:
June 21, 2011
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Subsidiaries
㈜클리노믹스
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
No results were found for this company.

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?